- The
company projects $19 million total revenue in 2019 and up to $104 million
in 2020 as it scales operations to meet rising global demand
- Hemptown
USA obtained and grew one million rare CBG seeds for the 2019 growing
season, yielding 780,000 pounds of dried biomass, and producing 10.3-13.4
percent full-spectrum non-intoxicating cannabinoids
Hemptown
USA is a privately-owned grower of full-spectrum, feminized hemp using
premium-seed genetics. The company is the premier player on the cannabigerol
(CBG) market which remains strong even as the price of cannabidiol (CBD)
continues to experience price compression due to an explosion of hemp grown.
One of the key phytocannabinoids present in feminized hemp, CBG has been
attracting a lot of attention in the scientific community for its many
anti-inflammatory and anti-bacterial properties. CBG is the precursor cannabinoid
forming the basis for synthesis of all other cannabinoids, which is why it’s
often referred to as the “stem cell” or “mother” of cannabinoids.
These unique features lend CBG great therapeutic promise.
Studies show the compound can help regulate mood because it boosts anandamide,
the native “pleasure” molecule, and acts as a GABA reuptake
inhibitor (http://ibn.fm/6Aj5J).
Research also suggests that CBG is a potent anti-inflammatory and anti-cancer
agent (http://ibn.fm/ApDEA),
as well as a good treatment option for anxiety and depression. In addition,
research points to it having potential as an effective natural option for
addressing medical problems like glaucoma, inflammatory bowel disease,
neurological conditions, bladder disorders and bacterial conditions. CBG is
also the key compound in a new FDA application for the treatment of skin
conditions like psoriasis and eczema.
Research has however been limited due to the low
concentration of CBG in plants. Feminized hemp plants must normally be
harvested early in the growth process to capture the CBG before it changes
its form to CBD and tetrahydrocannabinol (THC), but Hemptown USA plants have
been designed to allow harvesting later at full maturity. They have also been
designed to be far richer in CBG (10-14 percent). In 2020 and beyond, the
company has exclusive rights to 20 percent of the latest and greatest novel
cannabinoids being produced by their genetics partner.
Hemptown just completed in the fall of 2019 a
2.1-million-pound harvest of both CBG and CDB rich dried hemp biomass and will
be scaling its down stream operations to meet global demand in the wake of the
successful 2019 growing season. According to Hemptown data, the company is on
track for 2019 revenue of $19 million and is projecting $104 million revenue
for 2020 once down stream extraction/production is in full swing. In 2018, the
company harvested 110,000 pounds of full-spectrum biomass with CBD content of
around 14 percent from its Oregon hemp farms.
The company grew over 1,500 acres in Oregon, Colorado and
Kentucky. The Oregon operation is focused exclusively on rare genetics and
plans to expand cultivation to 800 acres for the 2020 growing season. Combined
with its innovative harvesting measures, this uniquely positions Hemptown as
the largest producer of CBG in North America and the world.
The scarcity of CBG and growing demand for the compound have
led to an increase in popularity and market price for CBG-based products. In
the U.S., the price for CBG distillate/isolate is now five to ten times higher
than that of CBD oil and forecasts suggest that CBG will rival CBD’s popularity
over the next few years.
With an average margin of 70-80 percent, Hemptown offers a
diversified product line that includes top flower, distillate, biomass, isolate
and water-soluble ready. Several consumer brands are presently in development
with launch dates set for winter 2019. The benefits of Hemptown’s products for
beverage, food, and cosmetic companies include purity, potency, cost
effectiveness, and marketplace strength.
Headquartered in Portland, Oregon, Hemptown is a proven
grower of broad-spectrum hemp biomass using premium seed genetics that contain
less than 0.3 percent THC and exceptionally high CBD content of up to 20
percent. The company’s “soil to oil” methodology combines seasoned
professionals working in hand-picked agricultural microclimates located in
Oregon’s famed Emerald Triangle, as well as Kentucky and Colorado.
For more information, visit the company’s website at www.HemptownUSA.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment